Registration

Introduction

Conversion of the mushroom toxin Muscimol into THIP (Gaboxadol), a novel type of hypnotic and non-opoid analgesic

Identification and biological evaluation of high affinity TRPV1 (VR1) vanilloid receptor antagonists

Coffee break & poster session

High throughput surface activity profiling in the prediction of blood-brain-barrier permeation

Towards a molecular understanding of presynaptic function: emerging targets for drug action

Sandwich lunch & poster session

Medicinal chemistry of CB1 cannabinoid receptor antagonists

Optimisation of brain penetration in drug discovery

P-glycoprotein, the gatekeeper: influence on the tissue distribution of the 5-ht1a antagonist P-[ ¹⁸F]MPPF , an ex vivo study in rats

Coffee break & poster session

Quantitative in vivo microdialysis study on the influence of multidrug transporters on the blood-brain barrier passage of oxcarbazepine: concomitant use of hippocampal monoamines as pharmacodynamic markers for the anticonvulsant activity.

Discovery of GABA-A α2/3 subtype selective agonists for the treatment of anxiety

Closing remarks